Kimberly Campbell, NP
Adult Health · Jeffersonville, INNPI 1093945222
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations.
Across 161 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$459
- AstraZeneca$386
- Novartis$370
- E.r. Squibb & Sons, L.L.C.$303
- Boston Scientific$247
- Merck$205
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,06899%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 26 | $459 |
| AstraZeneca | 12 | $386 |
| Novartis | 23 | $370 |
| E.r. Squibb & Sons, L.L.C. | 17 | $303 |
| Boston Scientific | 12 | $247 |
| Merck | 11 | $205 |
| Pfizer | 10 | $168 |
| Boehringer Ingelheim | 6 | $116 |
| Abbott | 5 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $96 |
| Irhythm Technologies, Inc. | 1 | $90 |
| Johnson & Johnson | 5 | $79 |
| Philips North America LLC | 4 | $67 |
| Sanofi-aventis U.S. LLC | 3 | $54 |
| Bayer | 2 | $52 |
| Azurity Pharmaceuticals, Inc. | 3 | $47 |
| Esperion Therapeutics, Inc. | 3 | $43 |
| Atricure, Inc. | 2 | $41 |
| Novo Nordisk | 2 | $32 |
| Lexicon Pharmaceuticals, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| GSK | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Scpharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
How this compares
$3,088 in reported general payments places this provider in the 85th percentile of 391 adult health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 72 | $65,121 |
| BrilintaTicagrelor | 36 | $28,731 |
| XareltoRivaroxaban | 33 | $23,697 |
| EntrestoSacubitril/Valsartan | 11 | $13,221 |
| Ranolazine ErRanolazine | 48 | $8,470 |
| Repatha SureclickEvolocumab | 12 | $6,598 |
| Midodrine Hcl | 25 | $2,129 |
| Metoprolol Succinate | 151 | $1,496 |
| ClopidogrelClopidogrel Bisulfate | 144 | $1,070 |
| Prasugrel Hcl | 13 | $1,001 |
| Potassium Chloride | 40 | $815 |
| Bumetanide | 27 | $768 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 106 | $764 |
| Amlodipine Besylate | 148 | $643 |
| Dofetilide | 14 | $556 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $168 | $65,12172 claims |
| AstraZenecaBrilinta | $386 | $28,73136 claims |
| Johnson & JohnsonXarelto | $79 | $23,69733 claims |
| NovartisEntresto | $370 | $13,22111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 391 adult health providers in Indiana.
Other adult health in Jeffersonville
- Virginia NisbetJeffersonville$11K
- Carrie ChesherJeffersonville$7K
- Jennifer BerryIndianapolis$50K
- Tajuana DavisZionsville$31K
- Patricia Damron-RobinsonMerrillville$20K
- Terry RidgeCarmel$20K
- Kristine StarcevichMerrillville$19K
- Jolyn Holliday VezaGreenfield$17K
- Anna MatulewiczMishawaka$14K
- Ludmila Pichugena-EmersonMiddlebury$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.